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The evidence
Of the three studies examined, only two studies directly evaluated the prevalence of iatrogenic synovial sepsis following intra-articular injection. Two out of the three studies were retrospective analyses of medical records (Smith et al., 2018 and Steel et al., 2013) and one was a survey based study with retrospective analyses of medical records submitted by questionnaire respondents (Gillespie et al., 2016) . The searches also revealed an abstract by Smith et al. (2013) which was later published as a full study (Smith et al., 2018) and for the purposes of avoiding data replication, only the full study has been included. The scientific literature surrounding this topic was sparse and of inconsistent quality. There were no randomised controlled trials evaluating the risk of iatrogenic synovial sepsis following corticosteroid administration. Most studies comprised retrospective analyses of medical records, which are considered midlevel in the hierarchy of evidence-based medicine (Murad et al., 2016) . The number of cases of iatrogenic synovial sepsis was very low in all included studies; therefore evaluating risk factors using multivariable models may have been biased by a low number of events per variable. All included studies were likely to have insufficient statistical power to identify a true difference in incidence between different treatments (Peduzzi et al., 1996) .
PICO question
In horses, does treatment with intra-articular antimicrobials concurrently with intra-articular corticosteroids reduce the risk of iatrogenic synovial sepsis compared to intra-articular corticosteroids alone?
Clinical bottom line
From the current literature, there is no evidence showing that intra-articular injection of antibiotics in conjunction with corticosteroids reduces the risk of synovial sepsis. However, the intra-articular injection of polysulphated glycosaminoglycans (PSGAGs) in combination with corticosteroids was noted as a risk factor for developing iatrogenic synovial sepsis and therefore concurrent antibiotic injection when administering PSGAGs may be warranted. The reported frequency of infection following intra-articular injections was very low (0.02-0.08%). An overall prevalence of iatrogenic synovial sepsis following all intra-articular injections based on data from all included studies was calculated as 0.02% (CI 0.02-0.03%). However, due to the paucity of literature on the topic, further studies are required in this field to determine more accurate clinical recommendations. 
Veterinary Evidence

Summary of the evidence
Where prevalence and 95% confidence intervals (CI) were not provided in the publication, the author performed calculations where published data permitted using Epitools epidemiological calculators (Ausvet Pty Ltd., 2019). (Italics denote author calculations).  Non-sterile dressing applied to all except stifle and shoulder joints, where no dressing was applied.
Study design:
Retrospective and prospective descriptive study, with nested matched case-control.
Outcome studied: Diagnosis of septic arthritis within 1-19 days following intra-articular injection and identification of any risk factors for this complication. Septic arthritis was diagnosed if synovial fluid bacterial culture was positive or if synovial fluid analysis revealed elevated total leucocyte count (>5.0 x 10 9 /L) with a predominance of neutrophils (>80%) and increased total protein (>25 g/L).
Main findings: (relevant to PICO question):
 Of 16,624 joints injected in 1103 horses, septic arthritis occurred in only 13 joints (13 horses).  The risk of septic arthritis following intra-articular injection was one case per 1279 injections or 7.8 per 10,000 joints (prevalence 0.08% [CI 0.05-0.13%]).  Of the 13 septic cases, 12 horses were injected with a corticosteroid plus or minus sodium hyaluronate (individual case details unspecified) and one was injected with a homeopathic anti-inflammatory product.  Risk factors identified were veterinary surgeon and type of corticosteroid.  Betamethasone had a lower risk of septic arthritis than dexamethasone.  When data for each joint location was compared there was no significant difference in the number of cases.  None of the 824 joints injected with amikacin developed septic arthritis. Of the 15,800 joints not injected with amikacin, 13 developed iatrogenic synovial sepsis. There was no statistically significant association between the absence of amikacin and development of synovial sepsis (Fisher's exact test P > 0.99).
Limitations:  The effect of the individual performing skin preparation was not studied because information was unavailable for seven of the 13 septic cases and for 50% of the nonseptic cases.  Study did not clarify whether veterinary surgeon or assistant performed skin preparation. Due to certain veterinary surgeons having an apparently higher rate of septic cases than others, this would have been useful information in order to determine if there were differences in aseptic technique despite a standardised procedure being in place.  Nonsterile dressing applied to all except stifle and shoulder joints, where no dressing was applied.  Medication doses were not recorded so association between corticosteroid dose and septic cases could not be evaluated.  Statistical validity of results is limited by a large number of injections with relatively low number of septic cases for comparison (resulting in a low number of events per variable for analysis of risk factors). Sample size: 241 surveys were returned containing details of 319,760 intraarticular injections.
Gillespie
Intervention details:  A link to an online survey was distributed to all members of the AAEP via email a total of three times between 17 March and 9 May 2014.  The survey consisted primarily of multiple choice questions about intra-articular injection site preparation methods, injection methods, types of medication used and aftercare.  Several open questions and written responses were also included.  Guidelines were provided for determining joint sepsis. Medical records for septic cases were requested and analysed.
Study design: Retrospective survey based cross-sectional study.
Outcome studied: Reported rate of joint sepsis following intra-articular injection.
Guidelines for diagnosing sepsis included one or more of: increased lameness score attributed to the injected joint, periarticular swelling, joint effusion, cloudy or turbid synovial fluid, elevated total protein of the synovial fluid and elevated nucleated cell count of synovial fluid.
Main findings: (relevant to PICO question):
Only 26.6% of respondents (64/241 surveys) provided data regarding joint sepsis. 67/319,760 injected joints became septic following injection; 2.10 septic joints per 10,000 intra-articular injections (prevalence 0.02% [CI 0.02-0.03%]).
No significant reduction in joint sepsis was noted with the concurrent intra-articular injection of antimicrobials.
Infection rates were significantly lower when:  Veterinary surgeons prepared their own injection sites  Veterinary surgeons had fewer than 20 years of practice experience. Infection rates were significantly higher when:  Hair was removed at the injection site.
Some findings were significant on the univariable analysis but were not retained in the final multivariable model. These included:  Lower infection rates when the intra-articular injection site was prepared for longer than 7 minutes  Lower infection rates when surgeons wore sterile or non-sterile gloves when performing the injection  Higher infection rates when veterinary surgeons used the same needle to draw up medications and perform the injection. Intervention details:  1732 horses receiving therapeutic intra-synovial injections using standardised aseptic technique.  Records were cross-referenced against admissions of synovial sepsis cases to the hospital and against cytology submissions.  Post-medication sepsis was considered if the horse developed two or more of four signs of synovial sepsis within 8 weeks of medication (listed below) and failed to respond to conservative therapy.
Study design: Retrospective analysis of medical records.
Outcome studied: Prevalence of iatrogenic synovial sepsis following intra-synovial injections. Synovial sepsis was defined as any horse developing two or more of four signs, including lameness, joint distension, synovial white blood cell count >10 x 10 9 /L, or synovial total protein >25 g/L within 8 weeks of intra-synovial medication of the same joint. Cases that resolved with conservative therapy (short courses of non-steroidal anti-inflammatory drugs and antimicrobials) were not diagnosed as septic.
 Frequency of iatrogenic synovial sepsis was very low (0.04%, 4/9456).  89.3% of injections (3869/4331) included corticosteroids; 93.4% included amikacin (4044/4331). Dosages were not recorded.  Four horses developed iatrogenic synovial sepsis -two following injection of PSGAGs, one following triamcinolone acetonide combined with amikacin sulphate and one following triamcinolone acetonide alone.  Administration of intra-synovial PSGAGs was associated with an increased risk of iatrogenic synovial sepsis, though the 95% confidence intervals cross 0, therefore this finding was not statistically significant.  Concurrent injection of amikacin sulphate with any other intrasynovial medication was associated with a low risk of developing iatrogenic synovial sepsis (attributable risk -1.02%, [CI -2.21-0.16]), though the confidence interval crosses 0, therefore this finding was not statistically significant.
Limitations:  93.4% of injections (4044/4331) included a prophylactic antibiotic (amikacin sulphate) so true risk of sepsis without concurrent antimicrobial administration is difficult to quantify.  Dosages of medications were not recorded.  High proportion of racehorses within study population may limit external validity.  Case definition of synovial sepsis in relation to descriptive clinical 
Appraisal, application and reflection
The current literature suggests that the frequency of infection following all intra-articular injections (including corticosteroids, antimicrobials, anaesthetic agents, PSGAGs, combinations of the above and any other unspecified or unlisted medication included in the studies reviewed) is very low and equates to roughly one case per 1000 or 2364 injections, according to Steel From the studies examined, there is no evidence that injecting antibiotics in conjunction with corticosteroids reduces the frequency of synovial sepsis following intra-articular injection. There is some evidence indicating that the risk of iatrogenic synovial sepsis following intra-articular medication may be increased by a number of factors, including:  The veterinary surgeon not performing the skin preparation herself/himself  The veterinary surgeon being qualified for over 20 years  Clipping the injection site  Skin preparation with chlorhexidine for fewer than 7 minutes*  Not wearing gloves*  Using the same needle to draw up medications and to inject the joint* (* denotes factors that were statistically significant on univariable analysis though not on multivariable analysis (Gillespie et al., 2016))
One of the included studies provided weak evidence of an increased risk of synovial sepsis following the injection of PSGAGs. Smith et al. (2018) reported that injection of PSGAGs was positively associated with iatrogenic synovial sepsis, though this finding was not statistically significant. In an abstract found in the literature search (though not included in the Knowledge Summary as it was an unpublished proceedings expanded abstract), Bohlin et al. (2014) also reported that injection of PSGAGs in combination with corticosteroids appeared to increase the risk of infection. Although not included in the summarised evidence due to it not meeting the inclusion criteria, a paper by Gustafson et al. (1989) reported that PSGAGs potentiate the risk of iatrogenic infection. Gustafson found that intra-articular injection of 125 mg amikacin immediately after inoculating the joint with Staphylococcus aureus significantly decreased the potentiation of infection by the PSGAG. From this data, it can be concluded that concurrent injection with antimicrobials when injecting PSGAGs may be warranted. Further studies with larger sample sizes would be required to confirm whether concurrent antibiotic administration when injecting PSGAGs is necessary.
Responsible use of antimicrobials is of paramount importance across all health sectors, and making appropriate, evidence-based choices is crucial to preventing the development of antimicrobial resistance. Therefore, the following recommendations can be made:
 Sterile skin preparation should be performed for a minimum of 7 minutes when using chlorhexidine, ideally by the veterinary surgeon performing the intra-articular injection.  Gloves should be worn for skin preparation as well as for intra-articular injection.  Needles should be changed after drawing up medications and before intra-articular injection.  Veterinary surgeons should consider not clipping the injection site, though this will depend on the length of hair, visibility of landmarks and gross contamination of the surrounding hair and skin.  Intra-articular injection of antimicrobials is unlikely to be necessary, though may be warranted if PSGAGs are being injected.
Although some of the above factors were only statistically significant on univariable analysis rather than on multivariable analysis, they have been included in the clinical recommendations for performing intra-articular injections as they are factors that may be implemented with ease in a clinical setting. A systematic review of aseptic skin preparation procedures for intra-articular injections in horses would be of benefit to equine practitioners, with particular attention on clipping and the substance used for disinfection (e.g. chlorhexidine or iodine). An investigation of skin preparation protocols in relation to septic arthritis rates would also be of great benefit to equine practitioners.
The quality of the evidence included in this summary is mixed. Only three studies were found and one of those three did not provide enough information regarding exact medications injected (corticosteroids vs others) to accurately interpret the results with direct relevance to the PICO question (Gillespie et al., 2016) . None of the studies rank highly in the hierarchy of research and evidence-based medicine (Arlt & Heuwieser, 2016 and Murad et al., 2016) . The poor quality and heterogeneity of the studies precluded meta-analysis of their results. In answer to the PICO question, it can be concluded that injecting antibiotics in conjunction with corticosteroids is likely to be unnecessary. However, there is a paucity of strong, evidence based research on the subject. Although the available studies provide useful data, they have limited external validity and insufficient statistical power. Further studies are required in this area to reach a definitive conclusion for this particular PICO question. Given the very low frequency of iatrogenic synovial sepsis following intra-articular injection reported in the included studies, a randomised controlled trial is unlikely to be feasible and a multicenter case control study would likely be required in order to recruit an adequate number of cases to achieve sufficient statistical power.
Methodology Section
Search Strategy
Databases searched and dates covered: Reference lists and bibliographies of discovered articles were also examined to identify other relevant publications, none of which were found. 
